During the past decade, International Cancer Institute (ICI) conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "International Cancer Institute (ICI)" are "Sickle Cell Disease" (3 trials), "Vaso-occlusive Crisis" (3 trials), "Vaso-occlusive Pain Episode in Sickle Cell Disease" (3 trials), "Advanced or Metastatic Esophageal Squamous Cell Carcinoma" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "International Cancer Institute (ICI)" in a lesser frequency.

Most popular intervention types in "International Cancer Institute (ICI)" are "Drug" (7 trials). Other intervention types were less common.

The name of intervention was led by "Inclacumab" (3 trials), "Placebo" (3 trials), "Atezolizumab" (2 trials), "Atezolizumab Matching Placebo" (1 trials) and "Endocrine Therapy of Physician's Choice" (1 trials). Other intervention names were less common.

The vast majority of trials in "International Cancer Institute (ICI)" are 7 trials for "All" genders.

Currently, there are NaN active trials in "International Cancer Institute (ICI)". undefined are not yet recruiting, 6 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were undefined completed trials in International Cancer Institute (ICI), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in International Cancer Institute (ICI), 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".